about
LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complexGenetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging.Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.Lipid nanocarriers containing a levodopa prodrug with potential antiparkinsonian activity.Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease.Reducing eIF4E-eIF4G interactions restores the balance between protein synthesis and actin dynamics in fragile X syndrome model mice.d-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain.Leucine‐rich repeat kinase 2 ( LRRK 2) inhibitors differentially modulate glutamate release and Serine935 LRRK 2 phosphorylation in striatal and cerebrocortical synaptosomesIsoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse modelUPF2 leads to degradation of dendritically targeted mRNAs to regulate synaptic plasticity and cognitive functionInositol polyphosphate multikinase mediates extinction of fear memoryCell-type-specific drug-inducible protein synthesis inhibition demonstrates that memory consolidation requires rapid neuronal translation
P50
Q24298891-5DD28133-907F-4A60-AF55-D9E8BAE2D34CQ34325540-980B103A-6572-47C6-A1FE-6A8711746DA0Q37701053-8E593BE2-D040-4364-B4E3-095298C37844Q39061521-D8671393-8AF9-42C7-ACD8-9313D5A273C8Q40954917-A8009F3B-7F3C-4A0F-AFF6-6CD856865FA9Q47428570-E37EEA2C-9BB9-4526-B074-5167800309B3Q48281001-CF0F86D7-65BA-47E8-8994-72628EBFB4BBQ64286295-273F98F0-0F5B-4FCE-A760-388FD54A8CE4Q90649323-B26047CF-990F-4DD8-8EB7-E171DDEFB09AQ90859670-7C1503AE-3F1C-4B0C-B725-584B3606B710Q91258502-9879D9BB-C088-42CF-85A7-98E259923B80Q92784125-0A186764-E2CE-425B-984C-88A5C285CC2C
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1183-0101
@en
name
Francesco Longo
@ast
Francesco Longo
@en
Francesco Longo
@es
Francesco Longo
@nl
type
label
Francesco Longo
@ast
Francesco Longo
@en
Francesco Longo
@es
Francesco Longo
@nl
prefLabel
Francesco Longo
@ast
Francesco Longo
@en
Francesco Longo
@es
Francesco Longo
@nl
P106
P1153
55630270100
P21
P31
P496
0000-0002-1183-0101